Improving healthcare outcomes for cancer patients by increasing quality, safety and efficiency of IV Chemotherapy services

通过提高静脉化疗服务的质量、安全性和效率来改善癌症患者的医疗保健结果

• 批准号: 102114
• 金额: $ 85.86万
• 依托单位: MEDCURA TECHNOLOGIES LTD
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2015
• 资助国家: 英国
• 起止时间: 2015 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=102114
• 关键词: Improving; healthcare; outcomes; cancer; patients

The project aims to deliver an integrated digital platform for the management of IV Chemotherapy in hospital. IV Chemotherapy provision has many dangers. Ensuring patient safety & quality is critical. Inefficient order management, patient flow, data flow, capacity management, quality and safety monitoring and patient engagement has meant that these services are expensive, offer poor quality experience to patients and pose safety risks to patients. The platform will: 1) Manage & schedule the preparation and administration of Chemotherapy orders, 2) Manage purchase of raw materials, 3) control & audit the compounding of the IV product both in pharmacy & on the ward to Good Manufacturing Practice (GMP) standards, 4) Track & trace the correct IV product to the correct patient, 5) monitor the safe disposal of waste, 6) allow patients & their carers to have visibility of the process & schedule & provide feedback

该项目旨在提供一个综合的数字平台，用于在医院管理IV化疗的管理。 IV化学疗法提供有许多危险。确保患者的安全和质量至关重要。效率低下的订单管理，患者流量，数据流，容量管理，质量和安全监控以及患者参与度意味着这些服务昂贵，为患者提供质量差的经验，并对患者构成安全风险。该平台将：1）管理和安排化学疗法订单的准备和管理，2）管理购买原材料，3）控制和审核在药房和病房中iv iv产品的复合构成良好的制造实践（GMP）标准（GMP）标准，4）跟踪和跟踪正确的IV和跟踪正确的静脉输送产品，5）在正确的患者中，5）允许浪费和计划的供应，5）允许患者及其供应量，5）供应量，5）供应范围，5）供应范围，5）